IGF-1 Deficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which IGF-1 Deficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT00903110

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Seve…

The Increlex® Global Registry is a descriptive, multicenter, observational, prospective, open-ended, non interventional, post-authorisation surveillance registr…

United States500 participantsStarted 2008-12-09

Treatment: Increlex®

All recent trials (28 shown)

Not Yet RecruitingPhase 3

NCT07553351

GB06 Phase III Trial for Pediatric Growth Hormone Deficiency

This study aims to evaluate the efficacy and safety of GB06 (a biosimilar of Norditropin®FlexProTM from Novo Nordisk) for the treatment of growth disorders caus…

China192 participantsStarted 2026-05-01

Treatment: GB06, Norditropin®FlexProTM

Not Yet RecruitingNot Applicable

NCT07173036

Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification Accordin…

The METAB-BELGROW-LAGH study aims to prospectively evaluate the metabolic outcomes of Belgian children diagnosed with growth hormone deficiency (GHD) over a thr…

Location not specified300 participantsStarted 2026-03-01

Treatment: metabolic and auxological outcomes, metabolic and auxological outcomes

IGF-1 Deficiency

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Seve…

All recent trials (28 shown)

GB06 Phase III Trial for Pediatric Growth Hormone Deficiency

Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification Accordin…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Seve…

All recent trials (28 shown)

GB06 Phase III Trial for Pediatric Growth Hormone Deficiency

Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification Accordin…

The AgRP and GH/IGF-1 Axis in Children

IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency

rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency

Effect of a HIIT Program on Quality of Life, Executive Functions, and IGF-1 Response in Sedentary Young University Women

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?

AR, IGF-IR, IR and Peripheral Artery Disease

IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency

Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency

Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle

Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency

IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population

Effect of Maternal BMI and Type of Infants Feeding on IGF-1 in Infant

Interval Training and Hormones in Chronic Heart Failure

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like G…

Growth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGF…

Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission